RespireRx Pharmaceuticals Inc (fka RSPI)

[neuroinv]

Keep in mind that being transparent can be a double edged sword when it comes to the FDA--they don't like their dealings with companies to be transparent. So you have to decide which constituency you want companies to play to. Since the FDA holds the power, I tend to go in that direction.

I do hold companies accountable--and I do it in the context and style that I choose. 4% of NI Research's revenue comes from individual investor subscriptions. 96% comes from institutions, mainly pharma companies looking for licensing/partnering possibilities, some from VCs and funds. I don't market NeuroInvestment to individuals (if it was not for a few loyal longterm readers, I wouldnt even have an individual subscription option) and there is zero fiscal upside to my posting information about Cortex on this thread. So I certainly am not going to alter how I do my job in order to appease those who don't take the time to ask their own questions when the opportunity arises. My participation here continues only due to the fact that the interchange is often--albeit not always--intellectually stimulating and enjoyable. I like having alternate perspectives presented. Answering the same questions over and over again--that I could do without. Tolerating personalized potshots--I am moving towards a zero tolerance stance.

NeuroInvestment